Abstract
The Luminex single antigen bead (SAB) technology is ultra-sensitive and detects all IgG donor-specific antibodies (DSA) non-selectively. In this study, we used a novel C3d-SAB assay to identify clinically relevant complement-fixing antibodies and examined the association of C3d+DSA with antibody mediated rejection (AMR) in heart transplant recipients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
